| Literature DB >> 29756493 |
Chun-Lin Li1, Hai-Jun Wang1, Quan-Jin Si1, Jin Zhou1, Kai-Liang Li1, Yu Ding1.
Abstract
Objective This study was performed to evaluate the association between urinary sodium excretion and coronary heart disease (CHD) in hospitalized elderly patients in China. Methods The 24-h urinary excretion specimens of 541 patients were collected, and the serum creatinine concentration and urinary sodium/potassium ratio were measured. Associations were explored by multivariate logistic regression analysis. Results The mean 24-h urinary sodium excretion was 200.4 mmol, corresponding to 11.7 g of salt intake. Both of these values were higher in men than in women. The salt intake of 80- to 89-year-old patients was significantly lower than that of 70- to 79-year-old patients. The 24-h urinary sodium excretion and spot urine Na/K ratios were significantly higher in overweight/obese and hypertensive patients. The 24-h urinary sodium excretion of men who smoked was significantly higher than that of women. The spot urine Na/K ratio was significantly higher in patients with cerebral thrombosis. The urinary Na/K ratio, smoking status, and hypertension were independent risk factors for CHD. Conclusions This cross-sectional survey suggests that the Na/K ratio may better represent salt loading than Na excretion alone in studying the association between sodium intake and CHD. There was no association between sodium and CHD prevalence.Entities:
Keywords: Aged; coronary heart disease; dietary; sodium; sodium excretion; sodium/potassium ratio
Mesh:
Substances:
Year: 2018 PMID: 29756493 PMCID: PMC6134650 DOI: 10.1177/0300060518772222
Source DB: PubMed Journal: J Int Med Res ISSN: 0300-0605 Impact factor: 1.671
Patients’ characteristics
| Total(n = 541) | Men(n = 316) | Women(n = 225) | |
|---|---|---|---|
| General condition | |||
| Age, years | 82.8 ± 3.5 | 86.8 ± 4.2 | 80.9 ± 3.5 |
| BMI, kg/m2 | 24.32 ± 3.2 | 23.73 ± 2.0 | 25.30 ± 2.6 |
| Smoking | 93 | 72 | 21 |
| Drinking | 211 | 142 | 69 |
| SBP, mmHg | 133.7 ± 18.1 | 132.3 ± 18.0 | 134.5 ± 17.6 |
| DBP, mmHg | 78.7 ± 9.6 | 77.7 ± 8.9 | 79.6 ± 9.5 |
| Scr, µmol/L | 139.2 ± 19.5 | 138.9 ± 19.3 | 141.9 ± 20.5 |
| Basic disease | |||
| Hypertension | 366 | 226 | 140 |
| CHD | 287 | 175 | 112 |
| DM | 362 | 201 | 161 |
| Cerebral thrombosis | 209 | 127 | 82 |
| Dyslipidemia | 275 | 146 | 129 |
| Medication use | |||
| Aspirin | 402 | 245 | 157 |
| Clopidogrel | 238 | 121 | 117 |
| Statins | 364 | 202 | 162 |
| Beta blockers | 258 | 154 | 104 |
| Nitrates | 244 | 132 | 112 |
| ACEI/ARB | 248 | 141 | 107 |
| CCB | 297 | 182 | 115 |
| Urinary measurements | |||
| Urine volume, L | 2.8 ± 0.9 | 3.1 ± 0.3 | 2.6 ± 0.8 |
| Urine Na excretion, mmol/L | 193.4 ± 32.1 | 213.6 ± 36.2** | 189.2 ± 39.8 |
| Urine K excretion, mmol/L | 23.8 ± 3.1 | 24.6 ± 4.5** | 21.7 ± 4.6 |
Data are presented as mean ± standard deviation or number of patients.
CHD, coronary heart disease; DM, diabetes mellitus; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; Scr, serum creatinine; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker.
*P < 0.05, men vs. women; **P < 0.001, men vs. women.
Urinary sodium and potassium excretion and creatinine clearance rate in different age groups
| Sex | Age group, years | n | Urinary Na excretion (mmol/24 h) | Urinary K excretion (mmol/24 h) | Na/K ratio | CCR (mL/min) | Salt intake (g/d) |
|---|---|---|---|---|---|---|---|
| Men | 60–69 | 75 | 223.6 ± 18.2 | 70.1 ± 15.3 | 3.29 ± 1.56 | 153.6 ± 20.1 | 13.1 ± 1.1 |
| 70–79 | 94 | 218.3 ± 19.1 | 68.0 ± 14.7 | 3.31 ± 1.33 | 151.2 ± 19.8 | 12.7 ± 1.1 | |
| 80–89 | 96 | 182.5 ± 20.7 | 57.3 ± 13.6 | 3.35 ± 1.26 | 133.4 ± 18.6 | 10.6 ± 1.2 | |
| ≥90 | 51 | 178.4 ± 17.8 | 47.6 ± 12.2 | 3.26 ± 1.80 | 103.5 ± 20.5 | 10.4 ± 1.0 | |
| Subtotal | 316 | 211.4 ± 19.5 | 60.6 ± 13.8 | 3.32 ± 1.72 | 134.5 ± 20.5 | 12.4 ± 1.1 | |
| Women | 60–69 | 77 | 217.1 ± 19.3 | 68.2 ± 17.6 | 3.28 ± 2.06 | 150.1 ± 24.0 | 12.7 ± 1.5 |
| 70–79 | 53 | 195.7 ± 22.4 | 65.6 ± 16.9 | 3.38 ± 1.83 | 150.3 ± 21.2 | 11.4 ± 1.4 | |
| 80–89 | 65 | 175.9 ± 23.2 | 60.3 ± 12.8 | 3.51 ± 1.41 | 137.8 ± 23.4 | 10.3 ± 1.1 | |
| ≥90 | 30 | 166.0 ± 19.9 | 45.9 ± 13.1 | 3.40 ± 1.21 | 119.6 ± 18.7 | 9.7 ± 1.6 | |
| Subtotal | 225 | 200.2 ± 17.6 | 59.5 ± 12.7 | 3.36 ± 1.81 | 138.5 ± 20.5 | 11.7 ± 1.0 | |
| Total | 60–69 | 152 | 221.6 ± 31.1 | 68.3 ± 19.5 | 3.24 ± 1.93 | 151.2 ± 26.9 | 12.9 ± 1.8 |
| 70–79 | 147 | 205.8 ± 27.7 | 66.2 ± 18.5 | 3.20 ± 1.71 | 150.7 ± 21.8 | 12.0 ± 1.6 | |
| 80–89 | 161 | 181.1 ± 19.8 | 58.9 ± 16.6 | 3.37 ± 1.62 | 135.9 ± 19.5 | 10.6 ± 1.2 | |
| ≥90 | 81 | 172.5 ± 18.2 | 47.7 ± 13.1 | 3.65 ± 1.80 | 101.0 ± 19.9 | 10.1 ± 1.1 | |
| Subtotal | 541 | 200.4 ± 19.1 | 59.6 ± 17.3 | 3.36 ± 1.91 | 138.5 ± 20.5 | 11.7 ± 1.1 |
Data are presented as mean ± standard deviation.
Na/K ratio, sodium/potassium ratio; CCR, creatinine clearance rate.
Salt intake was estimated as follows: urinary sodium (mmol/L) × 24-h urine volume (L) × 58.5 g.
Association of clinical factors with urinary sodium excretion and spot urine Na/K ratio
| n | Urinary sodium excretion (mmol/24 h) | Spot urine Na/K ratio | |
|---|---|---|---|
| Sex | |||
| Men | 316 | 211.4 ± 19.5 | 3.32 ± 1.72 |
| Women | 225 | 200.2 ± 17.6 | 3.36 ± 1.81 |
| | 0.0001 | 0.7930 | |
| Obesity | |||
| Normal weight (BMI < 24 kg/m2) | 223 | 201.4 ± 19.5 | 3.25 ± 1.82 |
| Obese/overweight (BM ≥ 24 kg/m2) | 318 | 223.2 ± 17.6 | 3.58 ± 1.81 |
| | 0.0001 | 0.0378 | |
| Drinking | |||
| Yes | 211 | 203.6 ± 16.0 | 3.32 ± 1.62 |
| No | 330 | 200.8 ± 17.5 | 3.39 ± 1.73 |
| | 0.0612 | 0.6382 | |
| Smoking | |||
| Yes | 93 | 241.4 ± 15.5 | 3.42 ± 1.55 |
| No | 448 | 210.2 ± 18.6 | 3.17 ± 1.49 |
| | 0.0001 | 0.14 | |
| Hypertension | |||
| Yes | 366 | 236.4 ± 18.5 | 3.62 ± 1.31 |
| No | 205 | 215.2 ± 17.2 | 3.36 ± 1.25 |
| | 0.0001 | 0.0211 | |
| Coronary artery disease | |||
| Yes | 287 | 208.5 ± 16.3 | 3.56 ± 1.52 |
| No | 254 | 205.6 ± 15.9 | 3.26 ± 1.39 |
| | 0.0372 | 0.0174 | |
| Type 2 diabetes | |||
| Yes | 362 | 221.2 ± 19.1 | 3.39 ± 1.22 |
| No | 179 | 218.2 ± 16.6 | 3.34 ± 1.51 |
| | 0.0735 | 0.6793 | |
| Cerebral thrombosis | |||
| Yes | 209 | 208.1 ± 17.7 | 3.46 ± 1.26 |
| No | 332 | 205.8 ± 15.8 | 3.16 ± 1.60 |
| | 0.1163 | 0.0219 | |
| Dyslipidemia | |||
| Yes | 275 | 210.9 ± 19.6 | 3.39 ± 1.62 |
| No | 266 | 195.2 ± 17.3 | 3.21 ± 1.50 |
| | 0.0519 | 0.1809 | |
Data are presented as mean ± standard deviation unless otherwise indicated.
Na/K ratio, sodium/potassium ratio; BMI, body mass index.
Multivariate logistic regression analysis of relevant factors of coronary heart disease
| Variable | β | SE | Wald | OR(95% CI) |
|
|---|---|---|---|---|---|
| Age | 0.015 | 0.013 | 1.681 | 0.936(0.910–1.005) | 0.090 |
| BMI | 0.123 | 0.072 | 3.117 | 1.135(0.908–1.013) | 0.105 |
| Smoking | 0.058 | 0.030 | 4.501 | 1.311(1.092–1.379) | 0.007 |
| SBP | 0.125 | 0.026 | 3.528 | 1.205(0.902–1.315) | 0.128 |
| Na/K ratio | 0.139 | 0.063 | 6.212 | 1.210(1.125–1.520) | 0.008 |
| CCR | 0.078 | 0.071 | 1.108 | 1.075(0.945–1.200) | 0.075 |
| DM | 0.052 | 0.042 | 2.618 | 1.041(0.980–1.127) | 0.099 |
| Hypertension | 0.012 | 0.005 | 6.832 | 1.321(1.111–1.422) | 0.013 |
| Dyslipidemia | 0.015 | 0.025 | 3.528 | 1.105(0.862–1.215) | 0.138 |
BMI, body mass index; CCR, creatinine clearance rate; Na/K ratio, urinary sodium/potassium ratio; DM, diabetes mellitus; SE, standard error; OR, odds ratio; CI, confidence interval; SBP, systolic blood pressure.